Tamas Szendrei

Markusovszky Str 5
Szombathely, VA 9700, Hungary

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Flow cytometry in the differential diagnosis of myelodysplastic neoplasm with low blasts and cytopenia of other causes.

Flow cytometry in the differential diagnosis of myelodysplastic neoplasm with low blasts and cytopenia of other causes.

Journal: Pathology oncology research : POR

Published: April 29, 2024

Low-burden TP53 mutations represent frequent genetic events in CLL with an increased risk for treatment initiation.

Low-burden TP53 mutations represent frequent genetic events in CLL with an increased risk for treatment initiation.

Journal: The journal of pathology. Clinical research

Published: July 26, 2023

Parallel testing of liquid biopsy (ctDNA) and tissue biopsy samples reveals a higher frequency of EZH2 mutations in follicular lymphoma.

Parallel testing of liquid biopsy (ctDNA) and tissue biopsy samples reveals a higher frequency of EZH2 mutations in follicular lymphoma.

Journal: Journal of internal medicine

Published: June 01, 2023

Targeted Venetoclax Therapy in t(11;14) Multiple Myeloma: Real World Data From Seven Hungarian Centers.

Targeted Venetoclax Therapy in t(11;14) Multiple Myeloma: Real World Data From Seven Hungarian Centers.

Journal: Pathology oncology research : POR

Published: December 19, 2021

Beneficial Effect of Lenalidomide-Dexamethason Treatment in Relapsed/Refractory Multiple Myeloma Patients: Results of Real-Life Data From 11 Hungarian Centers.

Beneficial Effect of Lenalidomide-Dexamethason Treatment in Relapsed/Refractory Multiple Myeloma Patients: Results of Real-Life Data From 11 Hungarian Centers.

Journal: Pathology oncology research : POR

Published: October 01, 2020

Real-world data on the efficacy and safety of daratumumab treatment in Hungarian relapsed/refractory multiple myeloma patients.

Real-world data on the efficacy and safety of daratumumab treatment in Hungarian relapsed/refractory multiple myeloma patients.

Journal: International journal of hematology

Published: May 08, 2019

Impact of minimal residual disease detection after treatment of multiple myeloma

Impact of minimal residual disease detection after treatment of multiple myeloma

Journal: Orvosi hetilap

Published: March 26, 2019

Standard Dose of Ibrutinib is Effective in the Treatment of Bing-Neel Syndrome.

Standard Dose of Ibrutinib is Effective in the Treatment of Bing-Neel Syndrome.

Journal: Pathology oncology research : POR

Published: August 23, 2018

Real World Efficacy and Safety Results of Ixazomib Lenalidomide and Dexamethasone Combination in Relapsed/Refractory Multiple Myeloma: Data Collected from the Hungarian Ixazomib Named Patient Program.

Real World Efficacy and Safety Results of Ixazomib Lenalidomide and Dexamethasone Combination in Relapsed/Refractory Multiple Myeloma: Data Collected from the Hungarian Ixazomib Named Patient Program.

Journal: Pathology oncology research : POR

Published: June 23, 2018

Treatment outcome of patients with essential thrombocythemia at our department in Hungary

Treatment outcome of patients with essential thrombocythemia at our department in Hungary

Journal: Orvosi hetilap

Published: February 21, 2016

Successful treatment with rivaroxaban of an extended superficial vein thrombosis in a patient with acquired antithrombin deficiency due to Peg-asparaginase treatment.

Successful treatment with rivaroxaban of an extended superficial vein thrombosis in a patient with acquired antithrombin deficiency due to Peg-asparaginase treatment.

Journal: Annals of hematology

Published: September 27, 2014

Detection and impact of minimal residual disease on outcome of chronic lymphocytic leukemia

Detection and impact of minimal residual disease on outcome of chronic lymphocytic leukemia

Journal: Orvosi hetilap

Published: October 10, 2012

Showing 1-12 of 12

Last Updated: 09/26/2026